1 Study Coverage
1.1 Medical Foods for Inborn Errors of Metabolism Product Introduction
1.2 Market by Type
1.2.1 Global Medical Foods for Inborn Errors of Metabolism Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Amino Acid
1.2.3 Glytactin with GMP
1.2.4 Amino Acid-Modified Infant Formula With Iron
1.2.5 Low Protein Food
1.2.6 Others
1.3 Market by Application
1.3.1 Global Medical Foods for Inborn Errors of Metabolism Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Phenylketonuria (PKU)
1.3.3 Maple Syrup Urine Disease (MSUD)
1.3.4 Urea Cycle Disorders
1.3.5 Renal Disease
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Medical Foods for Inborn Errors of Metabolism Sales Estimates and Forecasts 2017-2028
2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue Estimates and Forecasts 2017-2028
2.3 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Medical Foods for Inborn Errors of Metabolism Sales by Region
2.4.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Region (2017-2022)
2.4.2 Global Sales Medical Foods for Inborn Errors of Metabolism by Region (2023-2028)
2.5 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region
2.5.1 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region (2017-2022)
2.5.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Manufacturers
3.1.1 Global Top Medical Foods for Inborn Errors of Metabolism Manufacturers by Sales (2017-2022)
3.1.2 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Foods for Inborn Errors of Metabolism in 2021
3.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Manufacturers
3.2.1 Global Medical Foods for Inborn Errors of Metabolism Revenue by Manufacturers (2017-2022)
3.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Medical Foods for Inborn Errors of Metabolism Revenue in 2021
3.3 Global Medical Foods for Inborn Errors of Metabolism Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Medical Foods for Inborn Errors of Metabolism Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Medical Foods for Inborn Errors of Metabolism Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Type
4.1.1 Global Medical Foods for Inborn Errors of Metabolism Historical Sales by Type (2017-2022)
4.1.2 Global Medical Foods for Inborn Errors of Metabolism Forecasted Sales by Type (2023-2028)
4.1.3 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2017-2028)
4.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Type
4.2.1 Global Medical Foods for Inborn Errors of Metabolism Historical Revenue by Type (2017-2022)
4.2.2 Global Medical Foods for Inborn Errors of Metabolism Forecasted Revenue by Type (2023-2028)
4.2.3 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2017-2028)
4.3 Global Medical Foods for Inborn Errors of Metabolism Price by Type
4.3.1 Global Medical Foods for Inborn Errors of Metabolism Price by Type (2017-2022)
4.3.2 Global Medical Foods for Inborn Errors of Metabolism Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Application
5.1.1 Global Medical Foods for Inborn Errors of Metabolism Historical Sales by Application (2017-2022)
5.1.2 Global Medical Foods for Inborn Errors of Metabolism Forecasted Sales by Application (2023-2028)
5.1.3 Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2017-2028)
5.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Application
5.2.1 Global Medical Foods for Inborn Errors of Metabolism Historical Revenue by Application (2017-2022)
5.2.2 Global Medical Foods for Inborn Errors of Metabolism Forecasted Revenue by Application (2023-2028)
5.2.3 Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2017-2028)
5.3 Global Medical Foods for Inborn Errors of Metabolism Price by Application
5.3.1 Global Medical Foods for Inborn Errors of Metabolism Price by Application (2017-2022)
5.3.2 Global Medical Foods for Inborn Errors of Metabolism Price Forecast by Application (2023-2028)
6 North America
6.1 North America Medical Foods for Inborn Errors of Metabolism Market Size by Type
6.1.1 North America Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2028)
6.1.2 North America Medical Foods for Inborn Errors of Metabolism Revenue by Type (2017-2028)
6.2 North America Medical Foods for Inborn Errors of Metabolism Market Size by Application
6.2.1 North America Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2028)
6.2.2 North America Medical Foods for Inborn Errors of Metabolism Revenue by Application (2017-2028)
6.3 North America Medical Foods for Inborn Errors of Metabolism Market Size by Country
6.3.1 North America Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2028)
6.3.2 North America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Medical Foods for Inborn Errors of Metabolism Market Size by Type
7.1.1 Europe Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2028)
7.1.2 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Type (2017-2028)
7.2 Europe Medical Foods for Inborn Errors of Metabolism Market Size by Application
7.2.1 Europe Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2028)
7.2.2 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Application (2017-2028)
7.3 Europe Medical Foods for Inborn Errors of Metabolism Market Size by Country
7.3.1 Europe Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2028)
7.3.2 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Medical Foods for Inborn Errors of Metabolism Market Size by Type
8.1.1 Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2028)
8.1.2 Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Type (2017-2028)
8.2 Asia Pacific Medical Foods for Inborn Errors of Metabolism Market Size by Application
8.2.1 Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2028)
8.2.2 Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Application (2017-2028)
8.3 Asia Pacific Medical Foods for Inborn Errors of Metabolism Market Size by Region
8.3.1 Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Region (2017-2028)
8.3.2 Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Medical Foods for Inborn Errors of Metabolism Market Size by Type
9.1.1 Latin America Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2028)
9.1.2 Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Type (2017-2028)
9.2 Latin America Medical Foods for Inborn Errors of Metabolism Market Size by Application
9.2.1 Latin America Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2028)
9.2.2 Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Application (2017-2028)
9.3 Latin America Medical Foods for Inborn Errors of Metabolism Market Size by Country
9.3.1 Latin America Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2028)
9.3.2 Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Size by Type
10.1.1 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2028)
10.1.2 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue by Type (2017-2028)
10.2 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Size by Application
10.2.1 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2028)
10.2.2 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue by Application (2017-2028)
10.3 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Size by Country
10.3.1 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2028)
10.3.2 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Nestlé
11.1.1 Nestlé Corporation Information
11.1.2 Nestlé Overview
11.1.3 Nestlé Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Nestlé Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Nestlé Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Overview
11.2.3 Abbott Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Recent Developments
11.3 Reckitt Benckiser Group
11.3.1 Reckitt Benckiser Group Corporation Information
11.3.2 Reckitt Benckiser Group Overview
11.3.3 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Reckitt Benckiser Group Recent Developments
11.4 Ajinomoto
11.4.1 Ajinomoto Corporation Information
11.4.2 Ajinomoto Overview
11.4.3 Ajinomoto Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ajinomoto Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ajinomoto Recent Developments
11.5 Solace Nutrition
11.5.1 Solace Nutrition Corporation Information
11.5.2 Solace Nutrition Overview
11.5.3 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Solace Nutrition Recent Developments
11.6 Primus Pharmaceuticals
11.6.1 Primus Pharmaceuticals Corporation Information
11.6.2 Primus Pharmaceuticals Overview
11.6.3 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Primus Pharmaceuticals Recent Developments
11.7 BioMarin Pharmaceutical
11.7.1 BioMarin Pharmaceutical Corporation Information
11.7.2 BioMarin Pharmaceutical Overview
11.7.3 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BioMarin Pharmaceutical Recent Developments
11.8 Danone SA
11.8.1 Danone SA Corporation Information
11.8.2 Danone SA Overview
11.8.3 Danone SA Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Danone SA Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Danone SA Recent Developments
11.9 Galen Limited
11.9.1 Galen Limited Corporation Information
11.9.2 Galen Limited Overview
11.9.3 Galen Limited Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Galen Limited Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Galen Limited Recent Developments
11.10 PKU-MDMIL
11.10.1 PKU-MDMIL Corporation Information
11.10.2 PKU-MDMIL Overview
11.10.3 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 PKU-MDMIL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Medical Foods for Inborn Errors of Metabolism Industry Chain Analysis
12.2 Medical Foods for Inborn Errors of Metabolism Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Medical Foods for Inborn Errors of Metabolism Production Mode & Process
12.4 Medical Foods for Inborn Errors of Metabolism Sales and Marketing
12.4.1 Medical Foods for Inborn Errors of Metabolism Sales Channels
12.4.2 Medical Foods for Inborn Errors of Metabolism Distributors
12.5 Medical Foods for Inborn Errors of Metabolism Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Medical Foods for Inborn Errors of Metabolism Industry Trends
13.2 Medical Foods for Inborn Errors of Metabolism Market Drivers
13.3 Medical Foods for Inborn Errors of Metabolism Market Challenges
13.4 Medical Foods for Inborn Errors of Metabolism Market Restraints
14 Key Findings in The Global Medical Foods for Inborn Errors of Metabolism Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Medical Foods for Inborn Errors of Metabolism Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Amino Acid
Table 3. Major Manufacturers of Glytactin with GMP
Table 4. Major Manufacturers of Amino Acid-Modified Infant Formula With Iron
Table 5. Major Manufacturers of Low Protein Food
Table 6. Major Manufacturers of Others
Table 7. Global Medical Foods for Inborn Errors of Metabolism Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Medical Foods for Inborn Errors of Metabolism Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Medical Foods for Inborn Errors of Metabolism Sales by Region (2017-2022) & (K Units)
Table 10. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2017-2022)
Table 11. Global Medical Foods for Inborn Errors of Metabolism Sales by Region (2023-2028) & (K Units)
Table 12. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2023-2028)
Table 13. Global Medical Foods for Inborn Errors of Metabolism Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Region (2017-2022)
Table 15. Global Medical Foods for Inborn Errors of Metabolism Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Region (2023-2028)
Table 17. Global Medical Foods for Inborn Errors of Metabolism Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Medical Foods for Inborn Errors of Metabolism Sales Share by Manufacturers (2017-2022)
Table 19. Global Medical Foods for Inborn Errors of Metabolism Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Medical Foods for Inborn Errors of Metabolism Revenue Share by Manufacturers (2017-2022)
Table 21. Medical Foods for Inborn Errors of Metabolism Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Medical Foods for Inborn Errors of Metabolism Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Medical Foods for Inborn Errors of Metabolism by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Foods for Inborn Errors of Metabolism as of 2021)
Table 24. Medical Foods for Inborn Errors of Metabolism Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Medical Foods for Inborn Errors of Metabolism Product Offered
Table 26. Date of Manufacturers Enter into Medical Foods for Inborn Errors of Metabolism Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2022) & (K Units)
Table 29. Global Medical Foods for Inborn Errors of Metabolism Sales by Type (2023-2028) & (K Units)
Table 30. Global Medical Foods for Inborn Errors of Metabolism Sales Share by Type (2017-2022)
Table 31. Global Medical Foods for Inborn Errors of Metabolism Sales Share by Type (2023-2028)
Table 32. Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Medical Foods for Inborn Errors of Metabolism Revenue Share by Type (2017-2022)
Table 35. Global Medical Foods for Inborn Errors of Metabolism Revenue Share by Type (2023-2028)
Table 36. Medical Foods for Inborn Errors of Metabolism Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Medical Foods for Inborn Errors of Metabolism Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2022) & (K Units)
Table 39. Global Medical Foods for Inborn Errors of Metabolism Sales by Application (2023-2028) & (K Units)
Table 40. Global Medical Foods for Inborn Errors of Metabolism Sales Share by Application (2017-2022)
Table 41. Global Medical Foods for Inborn Errors of Metabolism Sales Share by Application (2023-2028)
Table 42. Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Medical Foods for Inborn Errors of Metabolism Revenue Share by Application (2017-2022)
Table 45. Global Medical Foods for Inborn Errors of Metabolism Revenue Share by Application (2023-2028)
Table 46. Medical Foods for Inborn Errors of Metabolism Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Medical Foods for Inborn Errors of Metabolism Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2022) & (K Units)
Table 49. North America Medical Foods for Inborn Errors of Metabolism Sales by Type (2023-2028) & (K Units)
Table 50. North America Medical Foods for Inborn Errors of Metabolism Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Medical Foods for Inborn Errors of Metabolism Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2022) & (K Units)
Table 53. North America Medical Foods for Inborn Errors of Metabolism Sales by Application (2023-2028) & (K Units)
Table 54. North America Medical Foods for Inborn Errors of Metabolism Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Medical Foods for Inborn Errors of Metabolism Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2022) & (K Units)
Table 57. North America Medical Foods for Inborn Errors of Metabolism Sales by Country (2023-2028) & (K Units)
Table 58. North America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2022) & (K Units)
Table 61. Europe Medical Foods for Inborn Errors of Metabolism Sales by Type (2023-2028) & (K Units)
Table 62. Europe Medical Foods for Inborn Errors of Metabolism Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Medical Foods for Inborn Errors of Metabolism Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2022) & (K Units)
Table 65. Europe Medical Foods for Inborn Errors of Metabolism Sales by Application (2023-2028) & (K Units)
Table 66. Europe Medical Foods for Inborn Errors of Metabolism Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Medical Foods for Inborn Errors of Metabolism Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2022) & (K Units)
Table 69. Europe Medical Foods for Inborn Errors of Metabolism Sales by Country (2023-2028) & (K Units)
Table 70. Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Medical Foods for Inborn Errors of Metabolism Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Medical Foods for Inborn Errors of Metabolism Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Medical Foods for Inborn Errors of Metabolism Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country (2023-2028) & (US$ Million)
Table 108. Nestlé Corporation Information
Table 109. Nestlé Description and Major Businesses
Table 110. Nestlé Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. Nestlé Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Nestlé Recent Developments
Table 113. Abbott Corporation Information
Table 114. Abbott Description and Major Businesses
Table 115. Abbott Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Abbott Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Abbott Recent Developments
Table 118. Reckitt Benckiser Group Corporation Information
Table 119. Reckitt Benckiser Group Description and Major Businesses
Table 120. Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Reckitt Benckiser Group Recent Developments
Table 123. Ajinomoto Corporation Information
Table 124. Ajinomoto Description and Major Businesses
Table 125. Ajinomoto Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Ajinomoto Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Ajinomoto Recent Developments
Table 128. Solace Nutrition Corporation Information
Table 129. Solace Nutrition Description and Major Businesses
Table 130. Solace Nutrition Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Solace Nutrition Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Solace Nutrition Recent Developments
Table 133. Primus Pharmaceuticals Corporation Information
Table 134. Primus Pharmaceuticals Description and Major Businesses
Table 135. Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Primus Pharmaceuticals Recent Developments
Table 138. BioMarin Pharmaceutical Corporation Information
Table 139. BioMarin Pharmaceutical Description and Major Businesses
Table 140. BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. BioMarin Pharmaceutical Recent Developments
Table 143. Danone SA Corporation Information
Table 144. Danone SA Description and Major Businesses
Table 145. Danone SA Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Danone SA Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Danone SA Recent Developments
Table 148. Galen Limited Corporation Information
Table 149. Galen Limited Description and Major Businesses
Table 150. Galen Limited Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. Galen Limited Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Galen Limited Recent Developments
Table 153. PKU-MDMIL Corporation Information
Table 154. PKU-MDMIL Description and Major Businesses
Table 155. PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 156. PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. PKU-MDMIL Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Medical Foods for Inborn Errors of Metabolism Distributors List
Table 161. Medical Foods for Inborn Errors of Metabolism Customers List
Table 162. Medical Foods for Inborn Errors of Metabolism Market Trends
Table 163. Medical Foods for Inborn Errors of Metabolism Market Drivers
Table 164. Medical Foods for Inborn Errors of Metabolism Market Challenges
Table 165. Medical Foods for Inborn Errors of Metabolism Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Foods for Inborn Errors of Metabolism Product Picture
Figure 3. Global Medical Foods for Inborn Errors of Metabolism Market Share by Type in 2021 & 2028
Figure 3. Amino Acid Product Picture
Figure 4. Glytactin with GMP Product Picture
Figure 5. Amino Acid-Modified Infant Formula With Iron Product Picture
Figure 6. Low Protein Food Product Picture
Figure 7. Others Product Picture
Figure 8. Global Medical Foods for Inborn Errors of Metabolism Market Share by Application in 2021 & 2028
Figure 9. Phenylketonuria (PKU)
Figure 10. Maple Syrup Urine Disease (MSUD)
Figure 11. Urea Cycle Disorders
Figure 12. Renal Disease
Figure 13. Others
Figure 14. Medical Foods for Inborn Errors of Metabolism Report Years Considered
Figure 15. Global Medical Foods for Inborn Errors of Metabolism Sales 2017-2028 (K Units)
Figure 16. Global Medical Foods for Inborn Errors of Metabolism Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Medical Foods for Inborn Errors of Metabolism Revenue 2017-2028 (US$ Million)
Figure 18. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2017-2022)
Figure 20. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Region (2023-2028)
Figure 21. North America Medical Foods for Inborn Errors of Metabolism Sales YoY (2017-2028) & (K Units)
Figure 22. North America Medical Foods for Inborn Errors of Metabolism Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Medical Foods for Inborn Errors of Metabolism Sales YoY (2017-2028) & (K Units)
Figure 24. Europe Medical Foods for Inborn Errors of Metabolism Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Sales YoY (2017-2028) & (K Units)
Figure 26. Asia-Pacific Medical Foods for Inborn Errors of Metabolism Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Medical Foods for Inborn Errors of Metabolism Sales YoY (2017-2028) & (K Units)
Figure 28. Latin America Medical Foods for Inborn Errors of Metabolism Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Sales YoY (2017-2028) & (K Units)
Figure 30. Middle East & Africa Medical Foods for Inborn Errors of Metabolism Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Medical Foods for Inborn Errors of Metabolism Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Medical Foods for Inborn Errors of Metabolism in the World: Market Share by Medical Foods for Inborn Errors of Metabolism Revenue in 2021
Figure 33. Global Medical Foods for Inborn Errors of Metabolism Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2017-2028)
Figure 35. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2017-2028)
Figure 36. Global Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2017-2028)
Figure 37. Global Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2017-2028)
Figure 38. North America Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2017-2028)
Figure 39. North America Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2017-2028)
Figure 40. North America Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2017-2028)
Figure 41. North America Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2017-2028)
Figure 42. North America Medical Foods for Inborn Errors of Metabolism Sales Share by Country (2017-2028)
Figure 43. North America Medical Foods for Inborn Errors of Metabolism Revenue Share by Country (2017-2028)
Figure 44. United States Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2017-2028)
Figure 47. Europe Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2017-2028)
Figure 48. Europe Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2017-2028)
Figure 49. Europe Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2017-2028)
Figure 50. Europe Medical Foods for Inborn Errors of Metabolism Sales Share by Country (2017-2028)
Figure 51. Europe Medical Foods for Inborn Errors of Metabolism Revenue Share by Country (2017-2028)
Figure 52. Germany Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 53. France Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue Share by Region (2017-2028)
Figure 63. China Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 66. India Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 68. China Taiwan Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2017-2028)
Figure 73. Latin America Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2017-2028)
Figure 75. Latin America Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Medical Foods for Inborn Errors of Metabolism Sales Share by Country (2017-2028)
Figure 77. Latin America Medical Foods for Inborn Errors of Metabolism Revenue Share by Country (2017-2028)
Figure 78. Mexico Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue Share by Country (2017-2028)
Figure 87. Turkey Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 89. UAE Medical Foods for Inborn Errors of Metabolism Revenue (2017-2028) & (US$ Million)
Figure 90. Medical Foods for Inborn Errors of Metabolism Value Chain
Figure 91. Medical Foods for Inborn Errors of Metabolism Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
